008: Commitment To GMP With Dr. Shabbir Anik
Business Of Biotech
00:00
The Importance of Evaluating Risks in a CMT Development Plan
The executive team of a biotech must understand what the potential risks are in that CMT development plan, Dr. Shabir Enneek says. The only way you can develop your initial plan is based on assuming everything goes right the first time. "That's one of the most critical things that early on needs to be evaluated," he adds.
Play episode from 32:09
Transcript
